Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: Focus on DNA repair genes

Leukemia

Volumn 20, Issue 11, 2006, Pages 1978-1988

  Casorelli, I ^a   Tenedini, E ^b   Tagliafico, E ^b   Blasi, M F ^a   Giuliani, A ^a   Crescenzi, M ^a   Pelosi, E ^a   Testa, U ^a   Peschle, C ^a   Mele, L ^c   Diverio, D ^d   Breccia, M ^e   Lo Coco, F ^e   Ferrari, S ^b   Bignami, M ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c SAN FILIPPO NERI HOSPITAL   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD33 ANTIGEN; FLT3 LIGAND; GENOMIC DNA; HERMES ANTIGEN; HOX PROTEIN; PROTEIN C JUN; PROTEIN FOS;

ADULT; AGED; ARTICLE; CD34 SELECTION; CELL CYCLE; CLINICAL ARTICLE; DNA RECOMBINATION; DNA REPAIR; EXCISION REPAIR; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REPRESSION; GENETIC IDENTIFICATION; HUMAN; HUMAN CELL; MALE; MALIGNANT TRANSFORMATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMYELOCYTE; PROMYELOCYTIC LEUKEMIA; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SAMPLE; TRANSCRIPTION REGULATION; TREND STUDY; UPREGULATION;

EID: 33750321808     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404376     Document Type: Article

References (37)

1. Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 2002; 295: 1079-1082.
2. Segalla S, Rinaldi L, Kilstrup-Nielsen C, Badaracco G, Minucci S, Pelicci PG et al. Retinoic acid receptor alpha fusion to PML affects its transcriptional and chromatin-remodeling properties. Mol Cell Biol 2003; 23: 8795-8808.
3. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M et al. The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 1993; 74: 423-431.
4. Beaumont M, Sanz M, Carli PM, Maloisel F, Thomas X, Detourmignies L et al. Therapy-related acute promyelocytic leukemia. J Clin Oncol 2003; 21: 2123-2137.
5. Pulsoni A, Pagano L, Lo Coco F, Avvisati G, Mele L, Di Bona E et al. Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: The GIMEMA experience. Blood 2002; 100: 1972-1976.
6. Larson RA, Wernli M, Le Beau MM, Daly KM, Pape LH, Rowley JD et al. Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine. Blood 1988; 72: 1333-1339.
7. Estey EH. Prognosis and therapy of secondary myelodysplastic syndromes. Haematologica 1998; 83: 543-549.
8. Leone G, Voso MT, Sica S, Morosetti R, Pagano L. Therapy related leukemias: Susceptibility, prevention and treatment. Leuk Lymphoma 2001; 41: 255-276.
9. Ben-Yehuda D, Krichevsky S, Caspi O, Rund D, Polliack A, Abeliovich D et al. Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood 1996; 88: 4296-4303.
10. Sheikhha MH, Tobal K, Liu Yin JA. High level of microsatellite instability but not hypermethylation of mismatch repair genes in therapy-related and secondary acute myeloid leukaemia and myelodysplastic syndrome. Br J Haematol 2002; 117: 359-365.
11. Casorelli I, Offman J, Mele L, Pagano L, Sica S, D'Errico M et al. Drug treatment in the development of mismatch repair defective acute leukemia and myelodysplastic syndrome. DNA Repair 2003; 142: 1-13.
12. Bignami M, Casorelli I, Karran P. Mismatch repair and response to DNA-damaging antitumour therapies. Eur J Cancer 2003; 39: 2142-2149.
13. Pagano L, Pulsoni A, Tosti ME, Avvisati G, Mele L, Mele M et al. Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia. Br J Haematol 2001; 112: 109-117.
14. Liu WM, Mei R, Di X, Ryder TB, Hubbell E, Dee S et al. Analysis of high density expression microarrays with signed-rank call algorithms. Bioinformatics 2002; 18: 1593-1599.
15. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. Exploration, normalization, and summaries of high density oligonucleoticle array probe level data. Biostatistics 2003; 4: 249-264.
16. Li C, Wong WH. Model-based analysis of oligonucleoticle arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 2001; 98: 31-36.
17. Li C, Hung Wong W. Model-based analysis of oligonucleotide arrays: Model validation, design issues and standard error application. Genome Biol 2001; 2, (research0032.1-11).
18. Landgrebe J, Wurst W, Welzl G. 'Permutation-validated principal components analysis of microarray data. Genome Biol 2002; 3 (research0019.1-11).
19. Wang A, Gehan EA. Gene selection for microarray data analysis using principal component analysis. Stat Med 2005; 24: 2069-2087.
20. Topliss JG, Edwards RP. Chance factors in studies of quantitative structure-activity relationships. J Med Chem 1979; 22: 1238-1244.
21. Alter O, Brown PO, Botstein D. Singular value decomposition for genome-wide expression data processing and modeling. Proc Natl Acad Sci USA 2000; 97: 10101-10106.
22. Pittelkow Y, Wilson SR. Use of principal component analysis and the GE-biplot for the graphical exploration of gene expression data. Biometrics 2005; 61: 630-632 (Discussion 632-634).
23. Alcalay M, Meani N, Gelmetti V, Fantozzi A, Fagioli M, Orleth A et al. Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair. J Clin Invest 2003; 112: 1751-1761.
24. Bullinger L, Dohner K, Bair E, Frohling S, Schlenk RF, Tibshirani R et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004; 350: 1605-1616.
25. Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004; 350: 1617-1628.
26. Haferlach T, Kohlmann A, Schnittger S, Dugas M, Hiddemann W, Kern W et al. Global approach to the diagnosis of leukemia using gene expression profiling. Blood 2005; 106: 1189-1198.
27. Alter O, Golub GH. Reconstructing the pathways of a cellular system from genome-scale signals by using matrix and tensor computations. Proc Natl Acad Sci USA 2005; 102: 17559-17564.
28. Muller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S et al. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol Cell Biol 2004; 24: 2890-2904.
29. Walter MJ, Park JS, Lau SK, Li X, Lane AA, Nagarajan R et al. Expression profiling of murine acute promyelocytic leukemia cells reveals multiple model-dependent progression signatures. Mol Cell Biol 2004; 24: 10882-10893.
30. Thompson A, Quinn MF, Grimwade D, O'Neill CM, Ahmed MR, Grimes S et al. Global down-regulation of HOX gene expression in PML-RARalpha+acute promyelocytic leukemia identified by small-array real-time PCR. Blood 2003; 101: 1558-1565.
31. He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V et al. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. Proc Natl Acad Sci USA 1997; 94: 5302-5307.
32. Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M, Pelicci PG et al. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci USA 1997; 94: 2551-2556.
33. Draptchinskaia N, Gustavsson P, Andersson B, Pettersson M, Willig TN, Dianzani I et al. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet 1999; 21: 169-175.
34. Rusyn I, Asakura S, Pachkowski B, Bradford BU, Denissenko MF, Peters JM et al. Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: Identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators. Cancer Res 2004; 64: 1050-1057.
35. Worrillow LJ, Travis LB, Smith AG, Rollinson S, Smith AJ, Wild CP et al. An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents. Clin Cancer Res 2003; 9: 3012-3020.
36. Seedhouse C, Bainton R, Lewis M, Harding A, Russell N, Das-Gupta E. The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia. Blood 2002; 100: 3761-3766.
37. Mistry AR, Felix CA, Whitmarsh RJ, Mason A, Reiter A, Cassinat B et al. DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N Engl J Med 2005; 352: 1529-1538.